Authors

Iris Penner, PhD

Latest:

Managing Neuropsychological Impairment in Multiple Sclerosis

Jeffrey A. Wilken, PhD

Latest:

Continuing the Vision of June Halper: What's Next for CMSC

Kathleen Costello discusses her new role as interim CEO of the CMSC. She has the support of Jeff Wilken, CMSC president, and Tina Trott, CMSC director.

Marcin Uszynski, PhD

Latest:

Interrater Reliability of Four Sensory Measures in People with Multiple Sclerosis

Jennifer S. Graves, MD, PhD

Latest:

Cultivating the Multiple Sclerosis Workforce of the Future

Janet Morrison, PhD, RN, MSCN

Latest:

Experiences of African American Women with Multiple Sclerosis

Katja Kanelisto, MSc

Latest:

Self-reported Reasons for Changes in Performance of Daily Activities During a 2-Year Multidisciplinary Multiple Sclerosis Rehabilitation

Vinesh Pillay, MD

Latest:

Effectiveness of Three-Dimensional Multiple-Object Tracking in Patients with Multiple Sclerosis

Kelly Fellows, PhD

Latest:

Marijuana Use by Patients with Multiple Sclerosis

Gary Cutter, MD

Latest:

Longitudinal Assessment of Multiple Sclerosis Patients and Reimbursement Issues

María Sol Roman, BS

Latest:

Relevance and Impact of Social Support on Quality of Life for Persons With Multiple Sclerosis

Adriana Aguayo, MS

Latest:

Needs and Psychosocial Outcomes of Caregivers of Individuals with Multiple Sclerosis in Guadalajara, Mexico

Emily Davis, BA

Latest:

Dance for Multiple Sclerosis: A Systematic Review

Chungyi Chiu, PhD, CRC, LPC

Latest:

Barriers to the Accessibility and Continuity of Health-Care Services in People with Multiple Sclerosis

Christelle Heynike, BPhty

Latest:

Evaluation of a Fatigue Self-Management Program for People with Multiple Sclerosis

Tamanna Islam, MSc

Latest:

IJMSC Author Spotlight: Tamanna Islam, MSc, and Lisa Walker, PhD

IJMSC Author Spotlight shines a light on the people behind the research.

Jeffrey English, MD

Latest:

Methylprednisolone, Mycophenolate Mofetil, or Cyclophosphamide as Combination Therapy With Interferon Beta-1a in Patients With Multiple Sclerosis: Retrospective Study

Kenneth Johnson, MD

Latest:

Longitudinal Assessment of Multiple Sclerosis Patients and Reimbursement Issues

Amber R. Salter, MPH

Latest:

Symptomatic Management of Multiple Sclerosis–Associated Tremor Among Participants in the NARCOMS Registry

Helen Dale, MS

Latest:

What People with Newly Diagnosed MS (and their Families and Friends) Need to Know

Catherine Schuman, PhD

Latest:

Effect of Eszopiclone on Sleep Disturbances and Daytime Fatigue in Multiple Sclerosis Patients

Jim Stankovich, PhD

Latest:

Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic Disorders

Vanessa Zimmerman, MSN, MSCN

Latest:

Support Group Participation

Cecilia Yastremiz, BS

Latest:

Relevance and Impact of Social Support on Quality of Life for Persons With Multiple Sclerosis

Jennifer Smrtka, MSN, ARNP-C, MSCN

Latest:

Impact of Shared Decision Making on Disease-Modifying Drug Adherence in Multiple Sclerosis

Mary Ann Picone, MD

Latest:

Depression Levels and Interferon Treatment in People with Multiple Sclerosis

Douglas A. Wajda, PhD

Latest:

Use of a Short Version of the Activities-specific Balance Confidence Scale in Multiple Sclerosis

Laura Barlow, RTR, RMTR

Latest:

An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis

Cassidy Dean, BS

Latest:

Facilitators of and Barriers to Adherence to Dietary Interventions Perceived by Women With Multiple Sclerosis and Their Support Persons

P. K. Coyle, MD

Latest:

The Immunopathology of MS: Are There Discrete Heterogeneous Patterns?

Margaret Youngs, BA

Latest:

Preliminary Support of a Behavioral Intervention for Trait Conscientiousness in Multiple Sclerosis

<1
...
565758596061626364
...
97>